Abstract: A method can include receiving data characterizing a first property of an asset over a first time period. The method can also include receiving data characterizing user interaction with an interactive graphical object. The method can further include determining, by a predictive model, data characterizing the first property of the asset over a second time period. The determining can be based in part on the received data characterizing the user interaction. The method can also include rendering, in a graphical display space, one or more of a first plot of the received data characterizing the first property over the first time period and a second plot of the determined data characterizing the first property over the second time period.

Abstract: A method can include receiving data identifying an industrial asset. The method can also include receiving data characterizing one or more sensors configured to detect a first property of the asset. The method can further include determining a first graphical representation of the asset based on the received data identifying the industrial asset, and a second graphical representation of a first sensor of the one or more sensors based on the received data characterizing one or more properties of one or more sensors. The method can further include rendering, in a graphical display space, the first graphical representation and the second graphical representation. One or more visual properties of the second graphical representation can be indicative of one or more properties of the first sensor and/or the detected first property of the asset.

Abstract: The present invention relates to polymeric nanoparticles comprising salinomycin and methods for treating certain diseases comprising administering these polymeric nanoparticles to a subject in need thereof.

Abstract: A temperature regulating carrier to create ambient environment to negate negative effects of thermal environmental factors. The carrier is suitable for backpacking and other outdoor activities and can easily fit inside of a backpack or be clipped onto a harness, sled, or any other object. The carrier is formed of a multi-layer thermal blanket material having an outer fabric layer, an inner liner, and a thermal insulation layer formed of a synthetic amorphous silica on a non-woven, needled batting that is disposed between the outer fabric layer and the inner liner to provide a thermally insulated interior chamber.

Abstract: A method can include receiving data characterizing a first property of an asset over a first time period. The method can also include receiving data characterizing user interaction with an interactive graphical object. The method can further include determining, by a predictive model, data characterizing the first property of the asset over a second time period. The determining can be based in part on the received data characterizing the user interaction. The method can also include rendering, in a graphical display space, one or more of a first plot of the received data characterizing the first property over the first time period and a second plot of the determined data characterizing the first property over the second time period.

Abstract: A method can include receiving data identifying an industrial asset. The method can also include receiving data characterizing one or more sensors configured to detect a first property of the asset. The method can further include determining a first graphical representation of the asset based on the received data identifying the industrial asset, and a second graphical representation of a first sensor of the one or more sensors based on the received data characterizing one or more properties of one or more sensors. The method can further include rendering, in a graphical display space, the first graphical representation and the second graphical representation. One or more visual properties of the second graphical representation can be indicative of one or more properties of the first sensor and/or the detected first property of the asset.

Abstract: An investment structure and method including a fixed component and a contingent component for investing funds. The fixed component invests a portion of the funds in fixed income securities and generates principal plus fixed interest. The contingent component invests another portion of the funds in non-fixed income investments and generates contingent interest. The fixed interest is selectively distributed or re-invested in the fixed component, and the contingent interest is re-invested in the contingent component in order to boost the trading pool for that component and potentially increase the return on investment. One or more limited partnerships, limited liability companies, corporations or other limited liability entities invests the contingent component.

Abstract: Compositions and methods for treating cancer are described. Some of the methods include administering to a cancer patient in need thereof a substance, such as a carbonic anhydrase inhibitor, that at a therapeutic dose produces a metabolic acidosis in humans; and administering to the patient at least one of: (a) a monocarboxylate transport inhibitor; (b) a sodium-hydrogen exchange inhibitor; (c) a chloride-bicarbonate exchange inhibitor; or (d) a proton pump inhibitor; wherein the at least one of (a) through (d) is in an amount effective to induce selective cytotoxicity in cancer cells relative to noncancerous cells in humans.

Abstract: An investment structure and method including a fixed component and a contingent component for investing funds. The fixed component invests a portion of the funds in fixed income securities and generates principal plus fixed interest. The contingent component invests another portion of the funds in non-fixed income investments and generates contingent interest. The fixed interest is selectively distributed or re-invested in the fixed component, and the contingent interest is re-invested in the contingent component in order to boost the trading pool for that component and potentially increase the return on investment. One or more limited partnerships, limited liability companies, corporations or other limited liability entities invests the contingent component.

Abstract: The present invention relates to methods for providing a diagnosis, prognosis and/or risk stratification of a subject with heart failure, comprising determining the concentration of osteopontin (OPN) in the biological sample, preferably in a plasma sample. An OPN cut-off value is discloses as a valuable reference value. The present invention furthermore relates to the use of osteopontin as marker for diagnosis, prognosis and/or risk stratification of a subject with heart failure, the use of the determination of the osteopontin plasma concentration in a biological sample of a subject for diagnosis, prognosis and/or risk stratification of heart failure as well as kits for performing the methods and uses of the invention. The present invention allows particularly for risk stratification of patients with heart failure, such as mortality prediction and prognosis of heart failure severity.

Abstract: An investment structure including a fixed component and a contingent component for investing funds. The fixed component invests a portion of the funds in fixed income securities and generates principal plus fixed interest. The contingent component invests another portion of the funds in non-fixed income, securities and generates contingent interest. The fixed interest is selectively distributed or re-invested in the fixed component, and the contingent interest is re-invested in the contingent component in order to boost the trading pool for that component and potentially increase the return on investment.

Abstract: This disclosure relates to formulations and methods of suppressing appetite and eliciting satiety (sense of being filled) in mammals through the oral administration of an effective amount of an appetite suppressing moiety.

Abstract: Formulations and methods of suppressing appetite and eliciting satiety in mammals are described. In some embodiments, oral administration of an effective amount of an appetite-suppressing peptide, in a composition that increases the bioavailability of the appetite-suppressing peptide, are effective to produce a feeling of satiety.

Abstract: The invention relates generally to methods for isolation and culture of kidney stem cells, cells isolated by the methods, and therapeutic uses for those cells.

Abstract: An investment structure and method including a fixed component and a contingent component for investing funds. The fixed component invests a portion of the funds in fixed income securities and generates principal plus fixed interest. The contingent component invests another portion of the funds in non-fixed income investments and generates contingent interest. The fixed interest is selectively distributed or re-invested in the fixed component, and the contingent interest is re-invested in the contingent component in order to boost the trading pool for that component and potentially increase the return on investment. One or more limited partnerships, limited liability companies, corporations or other limited liability entities invests the contingent component.

Abstract: An ultrasound imaging system generates an ultrasound image that represents ultrasound intensity as a function of position within an object, such as a patient's body. An ultrasound intensity range of interest is selected, and one or more areas of the ultrasound image which represent ultrasound intensities within the selected intensity range are highlighted, typically with a distinctive color. The highlighting of a selected intensity range facilitates analysis of the image and, in particular, facilitates differentiation of tissue types. Highlighting is typically performed within a defined region of interest of the ultrasound image.